Novel computational model predicts significant irAEs in NSCLC patients based on proteomic profiling of one pre-treatment blood test.

New deep brain stimulation device coupled with powerful AI may improve therapy for treatment-resistant depression.

The review article, “The Potential of Blood Neurofilament Light as a Marker of Neurodegeneration in Alzheimer’s disease,” is published in the journal Brain.

As laboratory assays have evolved with improved performance, the clinical use of cardiac troponin (cTn) has also evolved beyond the context of myocardial infarction (MI). The ...

MS research.

Study led by Johns Hopkins Medicine in collaboration with Yale School of Medicine.

Walking up the stairs had become difficult for Louise, an otherwise healthy, active, and stubborn 85-year-old retired nurse. It was spring, and Louise figured that she was deconditioned...

There are approximately 69 million traumatic brain injuries (TBI) in the world every year.1 It is the leading cause of death and long-term disability among all trauma related ...

Johns Hopkins Medicine researchers identify biomarkers to predict chronic kidney disease risk in hospitalized patients with acute kidney injury.

Signaling in the bloodstream could make it easier for doctors to distinguish between most common sources of dementia.